NCT03535610 (EMBOSOFT I) is a NA clinical trial of Uterine Embolization in Uterine Leiomyoma, sponsored by Scitech Produtos Medicos SA.

Who is sponsoring NCT03535610?

NCT03535610 is sponsored by Scitech Produtos Medicos SA.

What drugs are being tested in NCT03535610?

Interventions in NCT03535610: Uterine Embolization.

What condition does NCT03535610 study?

NCT03535610 studies Uterine Leiomyoma.

Is NCT03535610 still recruiting?

NCT03535610 is currently completed. Last updated 4 September 2020.

Last reviewed 2020-09-04 · How we verify

NCT03535610: EMBOSOFT I

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.

Completed NA Last updated 4 September 2020

What this trial tests

NA trial testing Uterine Embolization in Uterine Leiomyoma in 32 participants. Completed in 20 May 2020.

Timeline

13 August 2018

Primary endpoint
20 February 2020

20 May 2020

Quick facts

Lead sponsor	Scitech Produtos Medicos SA
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	32
Start date	13 August 2018
Primary completion	20 February 2020
Estimated completion	20 May 2020
Sites	1 location across Brazil

Drugs / interventions tested

Uterine Embolization

Conditions studied

Uterine Leiomyoma — all drugs for Uterine Leiomyoma →

Sponsor

Scitech Produtos Medicos SA — full company profile →

Who can join

Adults 18 to 50, female only, with Uterine Leiomyoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the therapeutic response to uterine artery embolization in 30 patients with leiomyoma using the microspheres Embosoft (Embosoft® - Scitech Medical).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Uterine artery embolization with highly compressible calibrated microspheres for the treatment of uterine fibroids.
Szejnfeld D, Santos RFT, Kambara AM, Colli MBO, et al · · 2022 · cited 1× · PMID 35983349 · DOI 10.1590/0100-3984.2021.0123

Verify or expand the search:

Other Scitech Produtos Medicos SA trials

Trials by the same sponsor.

NCT07491107 — Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions · not yet recruiting
NCT05642663 — Observational Study of ALTUS Powered Stapler Used in Bariatric Surgery · active not recruiting
NCT03606629 — SOLARIS Endoprosthesis in Iliac Occlusive Disease · completed
NCT03780192 — INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique · unknown
NCT03471234 — Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03535610 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Scitech Produtos Medicos SA
Last refreshed: 4 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03535610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing